Recent News

• 04.23.2025 - Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
• 04.23.2025 - Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
• 04.18.2025 - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
• 04.18.2025 - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
• 03.21.2025 - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
• 03.21.2025 - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
• 03.13.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.03.2025 - TD Cowen’s 45th Annual Health Care Conference
• 02.27.2025 - Fourth quarter and Full-year 2024 Financial Results and Corporate Updates

Recent Filings

• 03.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities